Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Early treatment with low-molecular-weight heparin (LMWH) reduces the risk for death in patients ...

The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) ...

The standard initial treatment of hemodynamically stable patients with pulmonary embolism is intravenous unfractionated heparin, requiring laboratory monitoring and hospitalization. We conducted a ...

Anecdotal reports of subtherapeutic heparin have kept many cardiologists across the world on edge over the past couple of months, although no regulatory authority has yet confirmed a specific problem.

Are you taking Heparin? Are you aware of the dangers of combining Heparin with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side effects ...

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according ...

Scientists have explained how contaminated batches of the blood-thinner heparin were able to slip past traditional safety screens and kill dozens of patients recently in the United States and Germany.

New research reveals that patients receiving heparin therapy were diagnosed with Alzheimer's disease up to two years later, suggesting a possible protective effect of this common anticoagulant. Study: ...